News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
746,676 Results
Type
Article (64397)
Company Profile (298)
Press Release (681981)
Section
Business (212691)
Career Advice (2376)
Deals (36406)
Drug Delivery (99)
Drug Development (84453)
Employer Resources (175)
FDA (16554)
Job Trends (15535)
News (359305)
Policy (33971)
Tag
2024 BioCapital Digital (9)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (10)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (6)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (8)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (7)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2910)
Academic (1)
Accelerated approval (2)
Adcomms (22)
Allergies (80)
Alliances (52748)
ALS (80)
Alzheimer's disease (1397)
Antibody-drug conjugate (ADC) (106)
Approvals (16532)
Artificial intelligence (227)
Autoimmune disease (10)
Automation (14)
Bankruptcy (363)
Best Places to Work (11966)
BIOSECURE Act (19)
Biosimilars (94)
Biotechnology (204)
Bladder cancer (50)
Brain cancer (26)
Breast cancer (238)
Cancer (1855)
Cardiovascular disease (138)
Career advice (1978)
Career pathing (30)
CAR-T (137)
Cell therapy (396)
Cervical cancer (14)
Clinical research (67587)
Collaboration (738)
Compensation (402)
Complete response letters (19)
COVID-19 (2754)
CRISPR (34)
C-suite (193)
Cystic fibrosis (102)
Data (1750)
Decentralized trials (2)
Denatured (17)
Depression (40)
Diabetes (231)
Diagnostics (6528)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (112)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (69)
Earnings (87046)
Editorial (35)
Employer branding (22)
Employer resources (152)
Events (115750)
Executive appointments (616)
FDA (17555)
Featured Employer (55)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (663)
Gene editing (91)
Generative AI (21)
Gene therapy (270)
GLP-1 (700)
Government (4613)
Grass and pollen (4)
Guidances (46)
Healthcare (19593)
Huntington's disease (22)
IgA nephropathy (19)
Immunology and inflammation (95)
Indications (24)
Infectious disease (2878)
Inflammatory bowel disease (132)
Inflation Reduction Act (8)
Influenza (44)
Intellectual property (72)
Interviews (405)
IPO (16745)
IRA (44)
Job creations (4018)
Job search strategy (1685)
Kidney cancer (9)
Labor market (27)
Layoffs (469)
Leadership (16)
Legal (8220)
Liver cancer (71)
Lung cancer (271)
Lymphoma (123)
Machine learning (2)
Management (60)
Manufacturing (260)
MASH (59)
Medical device (13592)
Medtech (13597)
Mergers & acquisitions (20068)
Metabolic disorders (605)
Multiple sclerosis (63)
NASH (16)
Neurodegenerative disease (75)
Neuropsychiatric disorders (23)
Neuroscience (1850)
NextGen: Class of 2025 (6826)
Non-profit (4850)
Northern California (2248)
Now hiring (36)
Obesity (331)
Opinion (216)
Ovarian cancer (62)
Pain (74)
Pancreatic cancer (70)
Parkinson's disease (123)
Partnered (18)
Patents (185)
Patient recruitment (82)
Peanut (47)
People (59777)
Pharmaceutical (69)
Pharmacy benefit managers (18)
Phase I (21081)
Phase II (29652)
Phase III (22009)
Pipeline (825)
Podcasts (49)
Policy (110)
Postmarket research (2942)
Preclinical (9438)
Press Release (70)
Prostate cancer (86)
Psychedelics (33)
Radiopharmaceuticals (254)
Rare diseases (354)
Real estate (6486)
Recruiting (66)
Regulatory (22982)
Reports (43)
Research institute (2621)
Resumes & cover letters (391)
Rett syndrome (3)
RNA editing (1)
RSV (39)
Schizophrenia (63)
Series A (118)
Series B (69)
Service/supplier (18)
Sickle cell disease (52)
Southern California (1930)
Special edition (14)
Sponsored (30)
Startups (3824)
State (2)
Stomach cancer (13)
Supply chain (58)
The Weekly (31)
United States (19972)
Vaccines (677)
Venture capitalists (35)
Webinars (12)
Weight loss (230)
Women's health (31)
Worklife (13)
Date
Last 7 days (684)
Last 30 days (2783)
Last 365 days (34842)
2025 (6045)
2024 (36141)
2023 (41092)
2022 (52374)
2021 (56996)
2020 (55710)
2019 (48566)
2018 (36658)
2017 (33898)
2016 (33922)
2015 (40490)
2014 (34389)
2013 (30584)
2012 (32246)
2011 (32577)
2010 (31151)
Location
Africa (880)
Alabama (50)
Alaska (7)
Arizona (227)
Arkansas (12)
Asia (41452)
Australia (7234)
California (5143)
Canada (1798)
China (430)
Colorado (236)
Connecticut (244)
Delaware (114)
Europe (92896)
Florida (756)
Georgia (178)
Idaho (58)
Illinois (490)
India (22)
Indiana (279)
Iowa (7)
Japan (131)
Kansas (104)
Kentucky (24)
Louisiana (8)
Maine (60)
Maryland (800)
Massachusetts (3928)
Michigan (203)
Minnesota (360)
Mississippi (2)
Missouri (73)
Montana (30)
Nebraska (25)
Nevada (55)
New Hampshire (62)
New Jersey (1462)
New Mexico (30)
New York (1475)
North Carolina (930)
North Dakota (8)
Northern California (2248)
Ohio (184)
Oklahoma (13)
Oregon (33)
Pennsylvania (1165)
Puerto Rico (7)
Rhode Island (24)
South America (1244)
South Carolina (16)
South Dakota (1)
Southern California (1930)
Tennessee (86)
Texas (765)
Utah (160)
Virginia (123)
Washington D.C. (59)
Washington State (494)
West Virginia (3)
Wisconsin (46)
746,676 Results for "toronto research chemicals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
University of Toronto scientists appointed as GSK chairs will advance drug delivery research and vaccine education tools for healthcare professionals
The University of Toronto’s Leslie Dan Faculty of Pharmacy has announced the appointments of two leading scientists as endowed GSK research chairs.
April 23, 2024
·
5 min read
Cayman Chemical Expands Molecular Diagnostic Research Offerings Through Partnership with PCRassays.com
Cayman Chemical, a leading supplier of research tools for the life science community, has widened their portfolio to include molecular-based detection kits through a strategic partnership with PCRassays.com.
June 6, 2024
·
2 min read
BioMidwest
Chemical Insights Research Institute Shares its Latest Research Findings on PFAS Associated with Consumer and Commercial Textiles
Chemical Insights Research Institute of UL Research Institutes has released its first report on a multi-phase research study of per- and polyfluoroalkyl substances, commonly referred to as “forever chemicals,” associated with consumer and commercial textiles.
March 27, 2024
·
3 min read
Press Releases
NCCN Announces New Gastrointestinal Cancer Research Grants in Collaboration with Taiho Oncology, Inc.
February 26, 2025
·
4 min read
Press Releases
Amaran Biotech Signs MOU with Nippon Fine Chemical
March 7, 2025
·
3 min read
Bio NC
Caidya Expands Global Presence with the Establishment of Caidya Canada Limited and New Office in Toronto
Caidya, a leading global, multi-therapeutic clinical research organization, is pleased to announce the establishment of its new legal entity, Caidya Canada Limited, and the opening of its new office in Toronto, Ontario.
April 1, 2024
·
2 min read
Deals
Satellos to Commence Trading on the Toronto Stock Exchange
Satellos Bioscience Inc. announced today that its common shares will commence trading on the Toronto Stock Exchange (“TSX”) as of the opening of trading tomorrow under the Company’s current trading symbol, “MSCL”.
February 14, 2024
·
5 min read
Press Releases
Ostia Sciences Inc. Secures Over $1 Million CAD in Seed Investment Round, Finalizes IP Assignment with the University of Toronto, and Prepares First Prototype for Groundbreaking Microbiome Technology
October 1, 2024
·
1 min read
Press Releases
Key Brain Chemical Can “Pause” Pregnancy After Conception
March 6, 2025
·
5 min read
Drug Development
Site Survival: Why Clinical Research Sites Need a Lifeline
Elisa Cascade, CPO at Advarra explains why addressing the challenges faced by clinical research sites is vital for improving patient trust and the overall viability of clinical trials.
February 19, 2025
·
1 min read
·
Lori Ellis
1 of 74,668
Next
